Interactions among the cannabinoids in the antagonism of the abdominal constriction response in the mouse
- PMID: 156380
- DOI: 10.1007/BF00432273
Interactions among the cannabinoids in the antagonism of the abdominal constriction response in the mouse
Abstract
The ability of delta 9-tetrahydrocannabinol (THC), cannabinol (CBN), cannabidiol (CBD), 11-OH THC and 8 alpha, 11-diOH THC to antagonise the abdominal constriction response in the mouse induced by formic acid, phenylquinone, 5-hydroxytryptamine, prostaglandin E1 (PGE1) and bradykinin was tested. THC was an effective antagonist against all nociceptive agents with an ED50 in all cases between 1.0 and 2.6 mg/kg. CBN, while also effective against all nociceptive agents, was less potent than THC, with an ED50 range between 46.2 and 112.5 mg/kg. CBD in doses as high as 200 mg/kg was without effect. Using PGE1 as the nociceptive agent, 11-OH THC was equipotent to THC while 8 alpha, 11-diOH THC was inactive. Naloxone, while able to antagonise the antinociceptive effect of morphine against formic acid-induced writhing, did not reverse the antinociceptive effects of THC. There were no pharmacological interactions between THC, CBD and CBN.
Similar articles
-
Effect of cannabinoids on the abdominal constriction response in mice: within cannabinoid interactions.Psychopharmacologia. 1976;46(1):83-5. doi: 10.1007/BF00421553. Psychopharmacologia. 1976. PMID: 1257370
-
Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.Eur J Pharmacol. 1986 Jun 17;125(2):301-4. doi: 10.1016/0014-2999(86)90042-7. Eur J Pharmacol. 1986. PMID: 3017729
-
Early cannabinoid exposure influences neuroendocrine and reproductive functions in mice: II. Postnatal effects.Pharmacol Biochem Behav. 1984 Jan;20(1):115-23. doi: 10.1016/0091-3057(84)90111-4. Pharmacol Biochem Behav. 1984. PMID: 6320228
-
Genetic effects of marijuana.Int J Addict. 1990-1991;25(1A):19-33. doi: 10.3109/10826089009067003. Int J Addict. 1990. PMID: 2174024 Review.
-
Ajulemic acid (CT3): a potent analog of the acid metabolites of THC.Curr Pharm Des. 2000 Sep;6(13):1339-45. doi: 10.2174/1381612003399473. Curr Pharm Des. 2000. PMID: 10903396 Review.
Cited by
-
Tolerance to, and symmetrical cross-tolerance between, cannabinol and delta 9-tetrahydrocannabinol.Experientia. 1981 Mar 15;37(3):295-6. doi: 10.1007/BF01991664. Experientia. 1981. PMID: 6263678 No abstract available.
-
Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.Drug Alcohol Depend. 2008 Apr 1;94(1-3):191-8. doi: 10.1016/j.drugalcdep.2007.11.017. Drug Alcohol Depend. 2008. PMID: 18206320 Free PMC article.
-
Gonadal hormone modulation of ∆9-tetrahydrocannabinol-induced antinociception and metabolism in female versus male rats.Pharmacol Biochem Behav. 2017 Jan;152:36-43. doi: 10.1016/j.pbb.2016.09.006. Epub 2016 Sep 24. Pharmacol Biochem Behav. 2017. PMID: 27670094 Free PMC article.
-
Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats.Front Pharmacol. 2017 Jun 21;8:391. doi: 10.3389/fphar.2017.00391. eCollection 2017. Front Pharmacol. 2017. PMID: 28680401 Free PMC article.
-
Interactions between THC and cannabidiol in mouse models of cannabinoid activity.Psychopharmacology (Berl). 2006 Jun;186(2):226-34. doi: 10.1007/s00213-006-0356-9. Epub 2006 Mar 30. Psychopharmacology (Berl). 2006. PMID: 16572263
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources